Provide Accreditation and Quality Management Services to National Blood Services in Africa under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH15 153403CONT17

Opportunity Information: Apply for CDC RFA GH15 153403CONT17

This grant opportunity, titled "Provide Accreditation and Quality Management Services to National Blood Services in Africa under the President's Emergency Plan for AIDS Relief (PEPFAR)," is a continuation funding announcement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), specifically through CDC's Center for Global Health (CGH). It is issued as a cooperative agreement, which usually means the CDC expects to have substantial involvement in guiding or collaborating on the work rather than simply issuing funds and stepping back. The overall focus is health, and the work described centers on strengthening national blood services across Africa by supporting accreditation and quality management services. In practical terms, this points to efforts that help blood services meet recognized standards, improve systems that ensure safe blood collection and transfusion practices, and maintain consistent quality across operations, all of which align with PEPFAR goals of reducing HIV transmission risks and improving health system performance.

The funding opportunity number is CDC RFA GH15-153403CONT17, and it is categorized as continuation funding, indicating it is intended to extend or continue previously supported work rather than launch an entirely new initiative. The CFDA number listed is 93.067, which is a CDC global health assistance catalog identifier often associated with international HIV/AIDS and related public health programming. The announcement was created on October 18, 2016, and had an original closing date of December 20, 2016, establishing the application window for eligible entities at that time.

The announcement anticipates up to 10 awards, suggesting the CDC expected multiple recipients to carry out similar or complementary roles, potentially across different countries, regions, or technical components of blood service accreditation and quality management. The award ceiling is listed as 0, which typically means a maximum funding amount was not specified in the public summary and would either be determined by program needs, available appropriations, negotiations, or detailed guidance in the full announcement package. Eligibility is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)," which signals that the standard summary does not fully capture the eligible applicant types and that the detailed eligibility rules would be found in the full notice. In many CDC cooperative agreements of this type, eligible applicants can include certain non-profits, NGOs, academic institutions, and other organizations with demonstrated technical capacity, but the exact allowable categories would depend on the omitted eligibility section.

In terms of what the work entails, the title and description indicate two closely linked technical areas: accreditation support and quality management services for national blood services. Accreditation generally refers to helping blood services prepare for and achieve certification against recognized standards, which can involve gap assessments, developing standard operating procedures, training staff, establishing documentation and audit systems, and implementing corrective and preventive action processes. Quality management services are broader and continuous, often covering organizational governance for quality, internal quality control, external quality assessment participation, data-driven monitoring, incident management, and continuous improvement cycles. For national blood services, these systems are central to ensuring that screening, handling, storage, and distribution of blood products are performed safely and consistently, which directly supports PEPFAR objectives by helping reduce transfusion-transmitted infections and strengthening laboratory and clinical systems tied to HIV prevention and treatment.

Because this is a cooperative agreement tied to PEPFAR, the effort likely emphasizes measurable public health impact, adherence to U.S. government and CDC program expectations, and alignment with country-led priorities in Africa. Cooperative agreements often include structured reporting, monitoring and evaluation expectations, and close coordination with CDC technical staff and in-country stakeholders. The practical outcome the CDC is signaling here is a stronger, more standardized, and more reliable national blood system infrastructure that can sustain safe transfusion services and integrate quality practices over time, supporting broader HIV and health system goals.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Provide Accreditation and Quality Management Services to National Blood Services in Africa under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Oct 18, 2016.
• Applicants must submit their applications by Dec 20, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH15 153403CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: